Stay updated on Phase 1b Combo w/ Ribociclib & Alpelisib Clinical Trial
Sign up to get notified when there's something new on the Phase 1b Combo w/ Ribociclib & Alpelisib Clinical Trial page.

Latest updates to the Phase 1b Combo w/ Ribociclib & Alpelisib Clinical Trial page
- Check3 days agoChange DetectedA 403 Forbidden error page is now displayed for the study record, with minimal HTML including a 403 title and a Home link.SummaryDifference20%

- Check10 days agoChange DetectedThe page now reflects a status of Active, not recruiting and No longer looking for participants. It also adds the Vanderbilt-Ingram Cancer Center and Kenneth Caldwell, MD as the study site and investigator and expands the study to four treatment groups.SummaryDifference4%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6. This appears to be a minor platform update with no apparent changes to study details or page content.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page's revision indicator was updated from v3.6.4 to v3.6.5, indicating a small maintenance update. No user-facing content appears to be changed.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a new build of the page rendering. This appears to be a behind-the-scenes update and does not alter the study details.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page label has been updated to Revision: v3.6.3, replacing the previous Revision: v3.6.0. This indicates a newer version of the page, primarily affecting metadata rather than the study content.SummaryDifference0.0%

Stay in the know with updates to Phase 1b Combo w/ Ribociclib & Alpelisib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1b Combo w/ Ribociclib & Alpelisib Clinical Trial page.